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Abstract	21	
Background:		A	definitive	diagnosis	of	immune-mediated	hemolytic	anemia	(IMHA)	can	be	difficult	to	22	
make.	However,	it	is	critical	to	differentiate	IMHA	from	other	causes	of	anemia	due	to	the	impact	on	23	
prognosis	and	outcome	for	IMHA	patients.	Recently	published	American	College	of	Veterinary	Internal	24	
Medicine	recommendations	for	the	diagnosis	of	IMHA	should	be	followed	to	concurrently	confirm	25	
ongoing	anemia,	verify	in	vivo	hemolysis,	and	detect	anti-erythrocyte	antibodies.	The	reliability	of	26	
immunologic	IMHA	tests	varies	depending	on	which	test	is	used	and	how	it	is	performed.		27	
Objectives:		Our	aims	were	to	determine	which	tests	are	currently	used	in	veterinary	medicine	to	28	
diagnose	IMHA	and	to	review	the	utility	of	assays	that	have	historically	been	used	to	diagnose	IMHA.	29	
Methods:		A	short	survey	was	designed	to	see	which	diagnostic	tests	for	IMHA	were	currently	being	30	
used	by	veterinary	practices.	The	survey	was	distributed	via	list-serves	to	veterinarians	and	veterinary	31	
technologists.	A	literature	review	was	performed	to	report	the	utility	of	diagnostic	tests	for	the	diagnosis	32	
of	IMHA.	33	
Results:		Survey	respondents	indicated	variability	in	test	protocols	used	to	diagnose	IMHA.	Most	34	
respondents	perform	saline	agglutination	or	Coombs’	tests	to	detect	anti-erythrocyte	antibodies.	35	
Additional	tests	that	can	be	used	to	support	a	diagnosis	of	IMHA	are	discussed	in	this	review.	36	
Conclusions:		A	standardized	diagnostic	approach	should	be	followed	to	differentiate	IMHA	from	other	37	
causes	of	anemia.	Test	methodology	can	vary	from	one	laboratory	to	another,	and	clinicians	should	be	38	
familiar	with	the	procedures	used	by	their	laboratory.	39	
	40	
Key	Words:		Agglutination,	Anti-erythrocyte	antibody,	Coombs’,	Diagnosis,	Spherocytosis	41	
	42	
Introduction	43	
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Immune-mediated	hemolytic	anemia	(IMHA)	is	commonly	diagnosed	in	canine	patients	with	hemolytic	44	
anemia.	It	is	a	less	prevalent,	but	an	equally	important	cause	of	hemolytic	anemia	in	cats,	horses,	and	45	
cattle.1,2		While	there	are	certain	clinicopathologic	findings	supportive	of	an	IMHA	diagnosis	(e.g.,	46	
peripheral	blood	spherocytosis,	RBC	agglutination,	demonstration	of	immunoglobulins	attached	to	RBC	47	
membranes),	the	diagnosis	of	IMHA	is	often	presumptive.	Misdiagnosis	of	IMHA	is	problematic	because	48	
of	important	differences	in	treatment	decisions	and	prognostic	consequences	for	patients	with	IMHA	as	49	
compared	with	other	causes	of	anemia.3		Additionally,	it	is	critical	to	evaluate	patients	that	have	IMHA	50	
for	underlying	diseases	that	drive	the	immune-mediated	response.	This	article	summarizes	the	results	of	51	
a	short	survey	on	the	use	of	diagnostic	tests	for	IMHA	in	veterinary	medicine	and	reviews	the	utility	of	52	
diagnostic	tests	for	IMHA.	53	
	54	
Diagnosis	of	IMHA	55	
In	anemic	patients,	the	mechanism	causing	the	anemia	(decreased	RBC	production,	hemorrhage,	or	56	
hemolysis)	needs	to	be	determined.	A	CBC	(including	quantitative	data	and	a	qualitative	blood	film	57	
review)	provides	fundamental	information	needed	for	the	assessment	of	anemia.	Anemia	can	be	58	
classified	as	either	regenerative	or	nonregenerative	based	on	quantification	of	the	reticulocytosis	using	59	
an	absolute	reticulocyte	concentration	or	corrected	reticulocyte	percentage	in	the	sample.	If	the	anemia	60	
is	regenerative,	blood	loss	or	hemolytic	anemia	should	be	considered.	Blood	loss	anemia	can	often	be	61	
differentiated	from	hemolytic	anemia	using	clinical	examination	findings	and	additional	62	
clinicopathologic	data.	Specifically,	acute	hemorrhage	results	in	loss	of	serum	proteins	and,	63	
consequently,	decreased	serum	albumin	and	globulin	concentrations.	Although	blood	loss	typically	64	
results	in	a	strongly	regenerative	anemia,	chronic	hemorrhage	can	cause	a	poorly	regenerative	anemia	if	65	
blood	loss	leads	to	iron	depletion,	since	the	resultant	iron-restricted	erythropoiesis	impedes	reticulocyte	66	
production.	It	is	important	to	assess	patients	for	occult	blood	loss	as	gastrointestinal	and	urinary	blood	67	
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loss	can	be	easily	missed.	While	the	majority	of	IMHA	patients	present	with	a	regenerative	anemia,	this	68	
initial	classification	is	not	a	certainty.	IMHA	can	be	nonregenerative	or	pre-regenerative	if	there	has	69	
been	insufficient	time	for	a	clearly	regenerative	response	to	occur	(anemia	present	<	5-7	days)4	or	if	70	
immune-mediated	destruction	of	erythroid	precursors	is	occurring	(“precursor-targeted	immune-71	
mediated	anemia”).5					72	
	73	
It	is	vital	to	document	that	true	in	vivo	hemolysis	is	occurring	in	patients	with	IMHA.	Accordingly,	proper	74	
collection	of	blood	samples	is	critical	to	avoid	ex	vivo	hemolysis,	which	can	lead	to	false	decreases	in	RBC	75	
concentration,	hematocrit	(HCT),	and	packed	cell	volume	(PCV);	false	increases	in	mean	cell	hemoglobin	76	
concentration	(MCHC);	variable	alterations	in	serum	bilirubin	concentrations	(depending	on	the	77	
methodology	used);	and	can	also	interfere	with	several	other	serum	chemistry	values.6		Diagnostic	test	78	
results	that	support	in	vivo	hemolysis	are	provided	in	Table	1.	79	
	80	
To	distinguish	IMHA	from	other	causes	of	anemia,	an	American	College	of	Veterinary	Internal	Medicine	81	
(ACVIM)	consensus	statement	recommends	documenting	all	three	of	the	following	diagnostic	findings	as	82	
minimum	criteria	to	diagnose	IMHA	in	dogs:7		83	
1) Decreased	packed	cell	volume	(PCV)	84	
2) At	least	one	of	the	following	abnormalities	supportive	of	hemolysis:		erythrocyte	ghost	cells,	85	
hyperbilirubinemia,	bilirubinuria,	icterus,	hemoglobinemia,	or	hemoglobinuria	86	
3) A	positive	saline	agglutination	test	that	persists	with	washing	or	at	least	two	of	the	following:	87	
a) A	positive	saline	agglutination	test	without	washing	88	
b) ≥	5	spherocytes	per	1000×	microscopic	field	89	
c) Detection	of	anti-erythrocyte	antibodies	by	a	Coombs’	test	or	flow	cytometry	90	
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Note	that	erythrocyte	ghost	cell	numbers	can	markedly	increase	ex	vivo,	so	examination	of	a	freshly	91	
made	smear	(at	the	time	of	blood	collection)	is	recommended	to	assess	this	morphologic	abnormality.6	92	
	93	
A	short	survey	(Appendix	A)	to	determine	how	tests	are	being	used	to	diagnose	IMHA	was	sent	to	an	94	
undetermined	number	of	people	in	Australia,	Canada,	Europe,	and	the	United	States	via	list-serves	and	95	
email	messages.	Veterinary	practitioners	in	both	general	practice	and	specialty	hospitals,	veterinary	96	
clinical	pathologists,	and	medical	technologists	and	technicians	in	clinical	pathology	laboratories	were	97	
asked	to	reply.	Respondents	were	not	asked	to	self-identify.	Ninety-four	people	completed	at	least	the	98	
first	question	of	the	survey.		99	
	100	
The	hematology	parameters	that	>	75%	of	the	respondents	said	were	provided	with	a	CBC	are	listed	in	101	
Figure	1.	Seventy-two	people	(77%)	indicated	that,	when	needed,	a	saline	agglutination	test	was	102	
included	with	CBC	results.	An	additional	13	respondents	(14%)	did	not	include	a	saline	agglutination	test	103	
as	part	of	a	CB,	but	as	an	additional	test.	Seventy-two	people	(77%)	recommended	a	test	to	detect	anti-104	
erythrocyte	antibodies	(saline	agglutination	test,	Coombs	test,	and/or	flow	cytometry).	Additional	tests	105	
that	were	recommended	by	>	15	%	of	respondents	included	a	biochemistry	panel	(66%),	screening	for	106	
tick-borne	diseases	(60%),	urinalysis	(52%),	and	diagnostic	imaging	(34%).	107	
	108	
Several	tests	have	been	used	to	aid	in	the	diagnosis	of	IMHA,	none	of	which	are	100%	sensitive	and	109	
specific.	Differences	in	the	protocols	used	to	perform	diagnostic	tests	for	IMHA	can	dramatically	affect	110	
the	performance	of	the	test.8,9		Tests	for	IMHA	must	account	for	physical	properties	associated	with	111	
antibody-antigen	interactions,	one	of	which	is	temperature-dependent	antibody-antigen	binding.10		112	
Therefore,	the	Coombs’	test	is	often	carried	out	at	both	37˚C	and	4˚C.11		Additionally,	inclusion	criteria	113	
for	IMHA	patients	vary	between	references,	which	can	alter	the	assessment	of	test	performance.	Most	114	
6	
	
studies	evaluating	diagnostic	tests	for	canine	IMHA	list	auto-agglutination	or	spherocytosis	as	inclusion	115	
criteria.	However,	Reimer	et	al.	(1999)	concluded	that	2/70	(3%)	canine	patients	with	IMHA	did	not	have	116	
auto-agglutination	or	spherocytosis,	nor	did	they	have	polychromasia.12	117	
	118	
Genetics	119	
Several	dog	breeds	have	a	higher	incidence	of	IMHA	than	the	general	canine	population	including;		120	
cocker	spaniels,12–15	English	springer	spaniels,12	miniature	schnauzers,13,15	and	old	English	sheepdogs16;	121	
however,	a	specific	gene	association	with	IMHA	has	not	be	found.	A	few	studies	have	associated	the	122	
presence	of	specific	major	histocompatibility	complex	alleles	in	dogs	with	the	occurrence	of	immune-123	
mediated	disease,	but	the	predictive	value	of	these	associations	remains	uncertain.17–19		The	frequency	124	
of	specific	dog	erythrocyte	antigens	found	during	blood	typing	was	not	significantly	different	in	33	dogs	125	
with	IMHA	as	compared	to	1,014	dogs	without	IMHA.20		Therefore,	expectedly,	genetic	testing	was	not	126	
recommended	as	an	additional	test	for	IMHA	by	survey	respondents.	127	
	128	
Non-specific	Tests	for	Antibodies	129	
Two	proteins,	staphylococcal	protein	A	(SpA)	and	papain,	have	been	used	in	several	papers	to	document	130	
increased	immunoglobulin	in	serum	samples.	SpA	is	an	immunoglobulin	binding	protein	produced	by	131	
Staphylococcus	aureus	that	has	been	shown	to	be	more	sensitive	than	indirect	antiglobulin	tests	in	dogs	132	
with	IMHA.21	Papain	is	an	enzyme	that	digests	antibodies	into	three	50	kDa	segments	comprised	of	one	133	
fragment	crystallizable	(Fc)	and	two	fragment	antigen-binding	(Fab)	regions.	When	using	a	papain	test	to	134	
detect	anti-erythrocyte	antibodies,	false-positive	results	occur	in	up	to	3/16	(19%)	of	dogs.22		One	study	135	
tested	23	papain	positive	anemic	dogs	with	direct	and	indirect	antiglobulin	tests;	8/23	(35%)	dogs	were	136	
positive	using	a	direct	test	and	none	were	positive	using	an	indirect	test.23		Due	to	the	non-specific	137	
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nature	of	SpA	and	papain	reactions,	they	are	no	longer	recommended	as	diagnostic	tests	for	IMHA	and	138	
unsurprisingly	were	not	listed	as	additional	tests	used	by	survey	respondents.	139	
	140	
Auto-agglutination	141	
Red	blood	cell	agglutination	should	raise	suspicion	for	IMHA	(Fig.	2).	To	determine	whether	142	
agglutination	is	likely	related	to	the	presence	of	antibody	or	complement	on	the	surface	of	the	red	blood	143	
cell	(i.e.,	auto-agglutination),	a	saline	agglutination	test	should	be	performed.	It	is	important	to	note	that	144	
artifactual	agglutination/rouleaux	is	not	dispersed	in	all	patients	using	a	1:1	dilution.	However,	if	145	
agglutination	persists	after	washing	erythrocytes	at	least	three	times	in	isotonic	or	phosphate-buffered	146	
saline,	it	is	likely	that	the	erythrocyte	clumping	is	true	agglutination	rather	than	rouleaux	formation.	The	147	
occurrence	of	auto-agglutination	in	dogs	with	IMHA	varies	from	42%	to	86%.12–16	The	number	of	patients	148	
with	a	positive	saline	agglutination	test	is	decreased	when	erythrocytes	are	washed	extensively.24,25	149	
There	is	some	evidence	that	the	decrease	in	positive	saline	agglutination	tests	with	washing	is	due	to	a	150	
reduction	in	false-positive	results,25	but	increased	numbers	of	false-negative	results	should	also	be	151	
considered.		152	
		153	
Seventy	respondents	indicated	whether	they	evaluated	saline	agglutination	tests	macroscopically	or	154	
microscopically:	34	looked	for	microscopic	agglutination,	29	looked	for	macroscopic	and	microscopic	155	
agglutination,	and	seven	looked	at	the	sample	macroscopically	only.	Sixty-three	people	indicated	how	156	
they	dilute	blood	samples	for	a	saline	agglutination	test:	31	performed	a	1:4	dilution,	24	performed	a	1:1	157	
dilution,	and	eight	performed	both	a	1:1	and	a	1:4	dilution	of	the	sample.	Of	the	28	respondents	who	158	
indicated	whether	they	wash	RBCs	for	the	saline	agglutination	test,	16	used	unwashed	RBCs,	11	used	159	
washed	RBCs,	and	one	used	both.	160	
	161	
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Erythron	162	
Spherocytosis	is	often	used	as	an	inclusion	criterion	for	studies	of	dogs	with	IMHA	and	was	included	in	163	
CBC	data	by	90/94	(96%)	of	survey	respondents	(Fig.	1).	However,	IMHA	also	can	be	non-spherocytic,	as	164	
the	occurrence	of	spherocytosis	in	dogs	with	IMHA	ranges	from	61%	to	95%.12,13,15,16,24,26	Spherocytes	are	165	
generally	only	recognized	in	dogs	(owing	to	the	pronounced	central	pallor	of	their	erythrocytes).	In	166	
contrast,	spherocytes	are	rarely	identified	with	certainty	in	cats,	horses,	and	cattle	since	erythrocytes	167	
from	these	animals	lack	central	pallor	on	blood	smears.	168	
	169	
Spherocytosis	and	some	other	RBC	membrane	abnormalities	can	cause	increased	erythrocyte	fragility.27	170	
The	osmotic	fragility	of	erythrocytes	can	be	tested	by	diluting	whole	blood	in	progressively	decreasing	171	
concentrations	of	sodium	chloride	(NaCl),	incubating	the	samples	for	30	minutes	at	room-temperature,	172	
recording	absorbance	of	the	samples	at	540	nm,	and	then	creating	a	data	curve	assuming	that	the	173	
lowest	NaCl	concentration	causes	100%	hemolysis.27	RBC	hemolysis	occurs	as	a	result	of	a	loss	of	174	
osmotic	regulation	and	volume	control,	which	is	exacerbated	in	a	number	of	RBC	disorders.	Increased	175	
RBC	hemolysis	during	osmotic	fragility	testing	is	commonly	reported	in	spherocytic	conditions	(e.g.,	176	
IMHA),	but	can	be	seen	in	spectrin	deficiency,28	hereditary	stomatocytocytosis,29	intestinal	parasite-177	
associated	microcytosis,	Babesia	canis	infection,30	or	non-hemolytic	samples	that	are	lipemic.	178	
Erythrocyte	fragility	testing	is	not	commonly	available	to	practitioners	but	can	provide	support	for	179	
ongoing	hemolysis.31		One	study	observed	increased	erythrocyte	fragility	in	15/15	(100%)	direct	180	
antiglobuin	test	(DAT)	positive	and	4/12	(33%)	DAT	negative	anemic	dogs.25		None	(0/91)	of	the	survey	181	
respondents	indicated	that	they	recommended	osmotic	fragility	testing	for	patients	suspected	of	having	182	
IMHA.	183	
			184	
9	
	
Most	patients	with	IMHA	have	a	moderate	to	marked	regenerative	anemia.	A	reticulocyte	count	was	185	
listed	as	a	component	of	a	CBC	by	77/94	(82%)	of	the	survey	respondents	(Fig.	1).	The	occurrence	of	186	
reticulocytosis	in	dogs	with	IMHA	ranges	from	67%	to	82%.13,16,26		IMHA	patients	often	have	increased	187	
numbers	of	circulating	nucleated	RBCs	and/or	Howell-Jolly	bodies.	Interestingly,	reticulocyte	188	
hemoglobin	(HGB)	content	was	shown	to	be	decreased	in	5/14	(36%)	dogs	with	IMHA	suggesting	that	189	
iron-restricted	erythropoiesis	can	be	present	in	some	canine	IMHA	patients.32	190	
	191	
A	diagnosis	of	erythroid	hyperplasia	in	bone	marrow	samples	is	a	definitive	indication	of	erythrocyte	192	
regeneration.	It	is	noteworthy	that	Weinkle	et	al.	(2005)	found	23/45	(51%)	dogs	with	IMHA	that	193	
underwent	bone	marrow	analysis	had	erythroid	hyperplasia.13		Similarly,	another	study	that	analyzed	194	
bone	marrow	samples	from	dogs	with	IMHA	observed	erythroid	hyperplasia	in	6/11	(55%)	samples.15		195	
Extramedullary	hematopoiesis33	and	secondary	myelodysplasia34	also	have	been	reported	in	dogs	with	196	
IMHA.	Bone	marrow	evaluation	is	typically	recommended	for	suspected	IMHA	patients	that	have	a	197	
nonregenerative	anemia.	Low	numbers	of	survey	respondents	[6/91	(7%)]	indicated	that	they	198	
recommend	bone	marrow	aspiration	or	biopsy	to	aid	in	the	diagnosis	of	IMHA.	Two	of	these	199	
respondents	specified	that	this	recommendation	was	warranted	in	patients	with	persistent	200	
nonregenerative	anemia.	201	
	202	
Nonregenerative	anemia	has	been	reported	in	6/23	(26%)	canine	IMHA	patients	in	one	study24	and	6/20	203	
(30%)	in	another.15	In	a	retrospective	analysis	of	dogs	with	nonregenerative	anemia	in	which	a	bone	204	
marrow	sample	was	clinically	indicated,	55/82	(67%)	were	determined	to	have	IMHA	(based	on	the	205	
presence	of	either	Coombs’	positivity,	auto-agglutination,	or	>	30%	spherocytes).35	In	dogs	with	206	
nonregenerative	IMHA,	38/55	(69%)	had	erythroid	hyperplasia,	and	17/55	(31%)	showed	incomplete	207	
maturation	of	the	erythroid	line.35	In	another	study	of	canine	patients	with	a	nonregenerative	anemia	208	
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present	for	more	than	5	days,	41/43	(95%)	had	erythroid	hyperplasia	in	bone	marrow	samples,	23/43	209	
(54%)	had	a	spherocytosis,	and	20/35	(57%)	were	positive	by	DAT.36	To	determine	if	dogs	with	a	210	
nonregenerative	anemia	>	5	days	duration	have	precursor-targeted	immune-mediated	anemia,	bone	211	
marrow	should	be	evaluated	for	macrophage	phagocytosis	of	erythroid	precursors.5	Weiss	(2008)	also	212	
evaluated	57	cats	with	nonregenerative	anemia	in	which	bone	marrow	analysis	was	indicated.	213	
Approximately	half	of	the	cats	28/57	(49%)	were	determined	to	have	IMHA	(based	upon	measurement	214	
of	an	HCT	<	20%	and	either	Coombs’	positivity	or	auto-agglutination).35	In	cats	with	IMHA	and	215	
nonregenerative	anemia,	24/28	(86%)	had	erythroid	hyperplasia	and	4/28	(14%)	showed	maturation	216	
arrest	of	the	erythroid	line.35		In	another	study,	phagocytosis	of	erythroid	precursors	and	abnormal	217	
presence	of	stainable	iron	was	documented	in	the	bone	marrow	of	cats	with	both	primary	and	218	
secondary	IMHA.37	219	
	220	
In	cases	of	IMHA	with	RBC	agglutination	in	the	sample,	many	of	the	measured	or	calculated	values	of	the	221	
erythron	are	often	erroneous	[e.g.,	RBC	concentration,	mean	cell	volume	(MCV),	HCT,	mean	cell	222	
hemoglobin	(MCH),	MCHC,	red	cell	distribution	width	(RDW)]	as	impedance	counters	will	count	223	
erythrocyte	clumps	as	single	and	large	erythrocytes,	which	leads	to	a	significant	reduction	in	the	224	
numbers	of	RBCs	counted	and	an	increase	in	the	mean	size	of	the	cells.6		In	cases	of	intravascular	225	
hemolysis,	HGB	concentration	is	not	clinically	reliable,	as	it	represents	a	combination	of	free	(plasma)	226	
and	RBC	HGB.	If	it	is	available,	the	determination	of	the	cell	hemoglobin	concentration	mean	(CHCM)	227	
using	an	advanced	laser	cell	counter	could	help	assess	RBC	HGB.	228	
	229	
Leukon	230	
Abnormalities	in	leukocytes	are	commonly	observed	in	patients	with	IMHA.	Leukocytosis	was	reported	231	
in	43%	to	99%	of	dogs	with	IMHA	(WBC	concentrations	in	these	reports	ranged	from	5,300	cells/µL	to	232	
11	
	
105,700	cells/µL).12,15,38,39		In	one	study,	decreased	survival	time	of	dogs	with	IMHA	was	associated	with	233	
leukocytosis	and	lymphopenia,40	while	lymphocytosis	was	a	positive	prognostic	factor	in	cats	with	234	
IMHA.37		Neutrophil	left	shifts	were	noted	in	up	to	16/20	(80%)	of	dogs	with	IMHA.15		One	paper	235	
observed	decreased	survival	rates	in	dogs	with	IMHA	with	band	neutrophil	concentrations	≥	3000	236	
cells/µL.13	237	
	238	
IMHA	patients	with	inflammatory	leukograms	typically	have	acute	patterns	such	as	a	neutrophilia	with	a	239	
left	shift,	lymphopenia,	eosinopenia,	and	monocytosis.15		In	severe	inflammatory	and	erythroid	240	
regenerative	conditions,	a	leukoerythroblastic	pattern	can	be	observed	with	a	highly	acute	inflammatory	241	
leukogram	and	a	high	percentage	of	nucleated	RBCs	in	different	stages	of	maturation.15		Rubricytosis	242	
causes	a	false	increase	in	the	automated	WBC	concentration	that	must	be	corrected	mathematically	243	
after	the	enumeration	of	nucleated	RBCs	by	blood	smear	review.	This	further	emphasizes	the	need	for	244	
blood	smear	examination,	which	can	also	help	with	the	detection	of	neutrophil	left-shifting	and	toxicity	245	
that	can	be	present	in	IMHA	cases.	Sixty-five/94	(69%)	survey	respondents	indicated	that	blood	smear	246	
evaluation	by	a	board-certified	clinical	pathologist	was	included	in	CBCs	they	performed	or	received	(Fig.	247	
1).	248	
	249	
Serum	Biochemistry	and	Urinalysis	250	
Abnormalities	in	biochemical	parameters	have	been	associated	with	the	clinical	outcomes	of	IMHA	251	
patients	(Table	2),	but	not	all	studies	report	the	same	findings.	An	increase	in	total	bilirubin	252	
concentrations	was	observed	in	60%	to	100%	of	dogs	with	IMHA.12,15,26		It	is	important	to	note	that	253	
increased	conjugated	bilirubin	can	interfere	with	phosphorus	measurements	leading	to	254	
pseudohypophosphatemia	in	patients	with	IMHA.41			Although	not	linked	to	decreased	survival,	Klag	et	255	
al.	(1993)	observed	hemoglobinemia	and/or	hemoglobinuria	in	4/42	(10%)	dogs	with	IMHA.26		There	are	256	
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also	a	few	case	studies	of	dogs	with	IMHA	with	biochemical	abnormalities	consistent	with	distal	renal	257	
tubular	acidosis.42		In	cats	with	IMHA,	hyperglobulinemia	is	reported	to	be	a	positive	prognostic	factor.37		258	
Biochemistry	profiles	were	recommended	as	additional	tests	for	suspected	IMHA	patients	by	60/91	259	
(66%)	of	survey	respondents.	260	
	261	
Additional	serum	protein	parameters	have	been	reported	to	be	altered	in	dogs	with	IMHA.	For	example,	262	
cardiac	troponin	I	was	>	0.1	ng/mL	in	20/27	(74%)	dogs	with	IMHA	(authors	indicated	that	<	0.1	ng/mL	is	263	
expected	in	healthy	dogs,	but	a	true	reference	interval	was	not	provided).43		C-reactive	protein	was	264	
increased	in	dogs	with	IMHA	at	presentation.44–46		Alpha-1	acid	glycoprotein	also	was	increased	in	dogs	265	
with	IMHA,	while	albumin	can	be	decreased	at	presentation.45		Increased	serum	concentrations	of	266	
several	cytokines	have	been	reported	in	dogs	with	IMHA	(n	=	20)	as	compared	with	six	healthy	dogs.46		267	
Interleukin-15	(IL-15),	IL-18,	granulocyte-monocyte	colony	stimulating	factor,	and	monocyte	268	
chemoattractant	protein-1	concentrations	were	increased	in	animals	with	IMHA	that	died	≤	30	days	269	
after	hospital	admission.46		Similarly,	IL-2,	IL-6,	and	tumor	necrosis	factor-α	were	present	at	higher	270	
concentrations	in	dogs	with	primary	IMHA	(n	=	19)	when	compared	with	dogs	that	had	other	271	
inflammatory	diseases	(n	=	22)	or	healthy	dogs	(n	=	32).47		In	question	4,	none	of	the	survey	respondents	272	
indicated	that	they	recommended	these	protein	assays	to	help	diagnose	patients	with	IMHA.	273	
	274	
Thrombon	and	Coagulation	275	
Thrombocytopenia	is	reported	to	occur	in	29-70%	of	dogs	with	IMHA.12,14,15,26,38,39		In	a	study	of	151	dogs,	276	
a	platelet	concentration	<	150,000	platelets/µL	correlated	with	decreased	survival	rates.13		Also,	a	277	
decreased	mean	platelet	component	concentration	was	found	in	dogs	with	IMHA	(n	=	95)	as	compared	278	
with	healthy	dogs	(n	=	95)	or	sick	canine	patients	(n	=	95)48	which	could	indicate	increased	platelet	279	
activation	in	IMHA	patients.49	280	
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	281	
Considerations	for	severe	thrombocytopenia	include	a	consumptive	process	[e.g.,	disseminated	282	
intravascular	coagulation	(DIC),	pulmonary	thromboembolism	(PTE)]	or	a	concurrent	immune-mediated	283	
thrombocytopenia	(IMT).	In	humans,	concurrent	IMHA	and	IMT	have	been	termed	Evan’s	Syndrome.	284	
This	disease	process	likely	occurs	in	dogs;	however,	the	presence	of	concurrent	anti-erythrocyte	and	285	
anti-platelet	antibodies	has	rarely	been	documented	in	veterinary	patients.50,51		In	38	dogs	with	both	286	
anemia	and	thrombocytopenia,	18/38	(47%)	of	patients	were	positive	by	DAT	for	anti-erythrocyte	287	
antibodies.52		In	a	similar	study	of	21	dogs	with	concurrent	anemia	and	thrombocytopenia,	auto-288	
agglutination	that	persisted	after	washing	was	observed	6/21	(29%)	dogs,	and	two	of	three	dogs	tested	289	
by	DAT	were	positive.53	290	
	291	
Several	studies	have	assessed	coagulation	parameters	in	dogs	with	IMHA	(Table	3).	Importantly,	292	
increased	mortality	was	observed	in	dogs	with	IMHA	that	had	thrombocytopenia,	prolonged	293	
prothrombin	time	(PT),	prolonged	activated	partial	thromboplastin	time	(APTT),	decreased	fibrinogen,	294	
or	DIC.40		Reports	using	thromboelastography	determined	that	85-100%	of	dogs	with	IMHA	were	295	
hypercoagulable.54–56		Development	of	DIC	is	observed	in	between	10/31	(28%)14	and	9/20	(45%)15	dogs	296	
with	IMHA.	One	study	reported	that	thromboemboli	were	found	in	20/25	(80%)	IMHA	dogs	at	297	
necropsy.14		The	analysis	of	coagulation	parameters	is	typically	recommended	in	IMHA	patients	that	298	
have	clinical	signs	of	coagulopathy.	One	survey	respondent	indicated	in	Question	4	that	they	299	
recommended	measurement	of	D-dimers	in	patients	suspected	of	having	IMHA.		300	
	301	
Indirect	Antiglobulin	Tests	302	
Indirect	antiglobulin	tests	are	not	recommended	in	veterinary	species	due	to	low	sensitivities	and	303	
specificities.	When	these	studies	were	first	evaluated	for	utility	in	canine	patients	with	IMHA,	the	304	
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sensitivity	and	specificity	of	an	indirect	antiglobulin	test	were	62.5%	and	96.6%,	respectively.57		The	DAT	305	
performed	by	the	same	laboratory	had	a	83.3%	sensitivity	and	98.8%	specificity.57		None	of	the	survey	306	
participants	recommended	indirect	antiglobulin	tests	in	Question	4.	307	
	308	
Direct	Antiglobulin	Tests	(DATs)	309	
Various	methods	for	directly	detecting	RBC	surface-bound	anti-erythrocyte	immunoglobulin	(Ig)	and	310	
opsonizing	complement	protein	(C3)	are	available.	Of	the	72	respondents	who	recommended	a	test	to	311	
diagnose	IMHA	with	anti-erythrocyte	antibodies,	66	recommended	a	Coombs’	test,	three	recommended	312	
flow	cytometry	and	a	Coombs’	test,	two	recommended	flow	cytometry	alone,	and	one	recommended	313	
flow	cytometry	and	a	Coombs’	test	at	4°C.	314	
	315	
Coombs’	Tests	316	
Coombs’	tests	are	often	performed	using	a	microtiter	plate	format.	Additional	methods	include	gel-317	
based	microcolumn,	immunochromatographic	strip,	and	capillary	DAT	assays.	Good	agreement	has	been	318	
reported	between	results	of	the	Coombs’	test	and	these	methods.25		False-positive	DAT	results	have	319	
been	reported	in	anemic	dogs.	In	theory,	false-positive	results	could	be	due	to	technical	difficulties	(e.g.,	320	
nonspecific	absorption	of	the	antibody,	incomplete	washing,	contamination,	assignment	of	an	321	
inappropriate	cut	off)	but	patient	factors	are	critical	to	consider.	Dogs	that	recently	received	a	322	
transfusion	can	have	a	positive	DAT.8,58		Also,	dogs	with	an	autoimmune	disease	that	are	positive	for	323	
antinuclear	antibodies	have	been	reported	to	be	DAT	positive	without	conclusive	evidence	of	IMHA.59		324	
Additionally,	horses	with	equine	infectious	anemia	can	have	a	positive	Coombs’	test.60	325	
	326	
The	Coombs’	test	uses	species-specific	antibodies	to	detect	Ig	and/or	C3	bound	to	erythrocytes	in	a	327	
patient	blood	sample.	A	positive	test	results	in	RBC	agglutination.	Sixty-five	of	the	people	surveyed	328	
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specified	if	they	recommended	a	Coombs’	test	when	auto-agglutination	was	observed,		50	people	329	
recommended	a	Coombs’	test	if	no	auto-agglutination	was	seen	(7	specified	use	of	a	microtiter	plate,	330	
and	2	recommended	an	immunochromatographic	strip	DAT	assay).	Fifteen	people	recommended	a	331	
Coombs’	test	with	or	without	auto-agglutination	(1	specified	the	use	of	a	microtiter	plate,	and	another	332	
recommended	the	use	of	a	strip	DAT	assay).	The	authors	agree	with	the	recent	ACVIM	consensus	333	
statement,7	which	indicates	that	a	Coombs’	test	is	unnecessary	if	true	auto-agglutination	that	persists	334	
after	washing	is	present.	335	
	336	
When	a	Coombs’	test	is	warranted,	polyvalent	and	monovalent	test	antibodies	are	available.	These	337	
antibodies	are	pre-adsorbed	onto	RBCs	from	healthy	dogs	before	use	in	the	test.	False-negative	results	338	
can	occur	with	either	type	of	test	antibody;	therefore,	including	both	polyvalent	and	monovalent	339	
antibodies	in	a	Coombs’	test	can	be	beneficial.11		Including	both	polyvalent	and	monovalent	antibodies	340	
increased	test	performance	in	a	study	that	reported	a	sensitivity	of	82%	and	a	specificity	of	95%	when	341	
antibodies	were	combined.8	342	
	343	
The	antibody	binding	reaction	is	temperature-dependent,	so	it	is	recommended	that	testing	is	344	
performed	at	both	37°C	and	4°C.11		Thirty	people	specified	that	they	ran	a	Coombs’	test	at	37°C,	11	345	
respondents	performed	a	Coombs’	test	at	37°C	and	4°C,	1	respondent	performed	the	test	at	37°C	and	346	
room	temperature,	and	(as	mentioned	above)one	person	performed	flow	cytometry	plus	a	Coombs’	test	347	
at	4°C.	348	
	349	
Also,	prozone	effects	are	commonly	reported	when	agglutination	is	not	observed	at	low	serum	dilutions	350	
(i.e.,	high	antibody	concentrations)	but	is	observed	at	higher	serum	dilutions	(i.e.,	low	antibody	351	
concentrations).	This	is	due	to	the	presence	of	excess	immunoglobulins	that	interfere	with	agglutination	352	
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induced	by	the	interactions	of	the	test	antibodies	with	Ig	and	C3	on	the	RBCs.61		This	improper	test	353	
antibody	to	anti-RBC	Ig	ratio	leads	to	false-negative	results	if	there	are	not	enough	serial	serum	dilutions	354	
tested.	A	prozone	effect	was	observed	in	17/126	(13%)	samples	tested	by	Piek	et	al.	(2012).62			355	
	356	
The	reported	performance	of	Coombs’	tests	vary,	likely	due	to	different	samples,	protocols,	and	test	357	
reagents	that	are	used	at	different	laboratories.	Important	positive	control	samples	for	the	Coombs’	test	358	
include	Ig-coated	and	complement-coated	canine	RBCs,	but	these	reagents	are	not	readily	available.9		It	359	
has	been	reported	that	the	use	of	whole	blood	in	EDTA	or	acid	citrate	dextrose	(ACD)	yields	similar	360	
results;	however,	ACD	anticoagulants	were	preferred	in	one	study	because	of	increased	sample	361	
hemolysis	in	EDTA.9		False-negative	results	that	reduce	the	sensitivity,	and	negative	predictive	value	362	
(NPV)	of	the	Coombs’	test	can	be	caused	by	physical	properties	of	the	test	antibodies	(e.g.,	low	antibody	363	
affinity,	an	inappropriate	antibody	ratio,	steric	hindrance),	poor	technique	(e.g.,	excessive	washing,	364	
delayed	processing,	assignment	of	an	inappropriate	cut-off),	or	patient	factors	(drug-dependent	365	
reactions,	blood	transfusions,	steroid	administration).8	366	
	367	
In	dogs	with	IMHA,	one	study	reported	that	a	low	percentage,	17/46	(37%),	of	patients	had	positive	368	
Coombs’	test	results,12	but	other	studies	indicated	that	77%	of	dogs	with	IMHA	were	positive.13,14		In	a	369	
small	study	of	12	dogs,	the	sensitivity,	specificity,	positive	predictive	value	(PPV),	and	NPV		of	the	370	
Coombs’	test	was	58%,	100%,	100%,	and	62%,	respectively.63		Similarly,	Quigley	et	al.	(2001)	calculated	a	371	
PPV	of	100%	and	an	NPV	of	68%.64		In	a	study	of	cats	with	IMHA,	2/89	(2%)	healthy	cats	were	reported	372	
to	have	a	strongly	positive	Coombs’	test	at	37˚C.65		Another	study	reported	that	0/14	(0%)	nonanemic	373	
cats	and	18/55	(33%)	anemic	cats	were	Coombs’	positive.66		Of	the	18	Coombs’	positive	cats,	15	were	374	
diagnosed	with	primary	IMHA,	two	were	feline	leukemia	virus	positive	(FeLV),	and	one	had	375	
cholangiohepatitis.66		An	older	manuscript	indicated	a	weak	positive	Coombs’	test	at	4˚C	in	9/20	(45%)	376	
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healthy	cats	and	a	positive	Coombs’	test	at	4˚C	and	37˚C	in	16/20	(80%)	anemic	cats	(12	of	the	Coombs’	377	
positive	anemic	cats	were	FeLV	positive).67	378	
	379	
It	is	expected	that	transfusion	reactions	can	cause	positive	DAT	results.58,68,69		Honeckman	et	al.	380	
indicated	that	transfusions	given	3	to	21	days	before	a	Coombs’	test	could	be	particularly	problematic.58		381	
However,	only	one	study	was	found	that	reported	DAT	test	results	in	seven	dogs	that	had	been	given	a	382	
recent	transfusion;	results	of	two	DAT	test	kits	were	reported.8		Samples	were	interpreted	as	truly	383	
positive	for	five	dogs	(by	at	least	one	Coomb’s	test	kit),	falsely	positive	for	one	dog,	and	falsely	negative	384	
for	one	dog.	This	study	did	not	specify	the	length	of	time	between	when	the	transfusion	was	given	and	385	
when	the	diagnostic	testing	was	done.	Interestingly,	in	humans,	blood	typing	is	recommended	either	386	
prior	to	transfusion	or	a	minimum	of	3	months	after	transfusion	to	avoid	erroneous	results.70	387	
	388	
Ninety-one	of	the	94	survey	respondents	indicated	if	they	would	interpret	any	diagnostic	results	with	389	
caution	following	a	transfusion.	The	timeframe	of	concern	for	people	who	interpreted	results	with	more	390	
caution	varied	(Fig.	3).	It	is	evident	from	this	small	survey	that	there	is	uncertainty	if	recent	transfusion	391	
would	cause	false-positive	results	in	CBC,	agglutination,	or	DAT	assays.	392	
	393	
Flow	Cytometry	Methods	394	
Flow	cytometry	can	also	be	used	to	detect	immunoglobulins	bound	to	RBCs.	One	of	the	first	evaluations	395	
of	flow	cytometry	as	a	diagnostic	test	for	IMHA	compared	data	from	12	dogs	and	three	horses	with	396	
IMHA	to	12	healthy	animals	from	each	respective	species.63		They	reported	low	specificity	of	a	goat	anti-397	
equine	IgG	but	100%	specificity	of	goat	anti-equine	IgG	F(ab’)2	fragment	in	their	assay.	63		In	dogs,	by	398	
pooling	anti-canine	IgG,	IgM,	IgA,	and	C3	antibodies,	the	sensitivity	of	the	test	was	100%,	specificity	was	399	
87.5%,	PPV	was	92%,	and	NPV	was	100%.63		There	was	no	prozone	effect	with	this	assay.	63		Quigley	et	al.	400	
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(2001)	reported	a	PPV	of	100%,	and	an	NPV	of	93%	when	they	used	flow	cytometry	to	evaluate	13	dogs	401	
with	IMHA	and	13	healthy	dogs.64		In	2008,	Morley	et	al.	published	an	assessment	of	the	utility	of	flow	402	
cytometry	to	detect	anti-erythrocyte	antibodies	in	dogs.71		They	found	26/147	(18%)	anemic	patients	403	
had	detectable	anti-erythrocyte	antibodies.	This	included	17/22	(77%)	IMHA	patients,	5/14	(36%)	IMT	404	
patients,	and	3/71	(4%)	cancer	patients.	However,	12/145	(8%)	nonanemic	dogs	also	were	positive	for	405	
anti-erythrocyte	antibodies,	which	included	3/5	(60%)	patients	with	infectious	disease	and	5/81	(6%)	406	
cancer	patients,	and	the	test	had	a	PPV	of	70%	and		NPV	of	95%.	407	
	408	
Direct	Enzyme-Linked	Antiglobulin	Tests	(DELATs)	409	
Immunoglobulins	and	C3	bound	to	RBCs	are	detected	by	comparing	the	absorbance	of	patient	samples	410	
to	healthy	control	animals	in	the	DELAT.	Early	evaluation	of	a	DELAT	indicated	that	1	mg/mL	ρ-411	
nitrophenyl	phosphate	in	carbonate	buffer	is	the	preferred	substrate	for	the	reaction,	however	false-412	
positive	results	were	observed	in	31/60	(52%)	dogs	tested.72		Another	evaluation	of	DELAT	performance	413	
yielded	comparable	results	with	a	Coombs’	test;	12/23	(52%)	samples	were	Coombs’	positive,	while	414	
13/23	(57%)	were	DELAT	positive.73		To	the	authors’	knowledge,	this	test	for	IMHA	is	no	longer	readily	415	
available.	416	
	417	
Guidelines	for	Performing	Diagnostic	Tests	for	IMHA	418	
As	mentioned	previously,	technical	difficulties	and	test	protocols	can	profoundly	affect	the	performance	419	
of	diagnostic	tests	for	IMHA.	Tests	performed	at	4°C,	room	temperature,	and	37°C	can	provide	different	420	
results.	This	document	includes	two	example	protocols	for	saline	agglutination	testing	(Appendix	B)	and	421	
an	example	of	Coombs’	testing	(Appendix	C).	In	different	diagnostic	laboratories,	it	is	expected	that	422	
these	protocols	will	be	performed	differently	but	that	proper	procedures	will	yield	adequate	results.	423	
	424	
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Conclusions	425	
Making	a	definitive	diagnosis	of	IMHA	can	be	difficult	due	to	the	variability	in	patient	presentation	and	426	
diagnostic	test	performance.	Recommended	tests	for	diagnosing	IMHA	in	anemic	patients	include:		1)	a	427	
CBC	with	verified	reticulocyte	count,	manual	PCV	with	assessment	of	plasma	color,	and	microscopic	428	
examination	of	a	(preferably	fresh)	blood	smear,	2)	serum	chemistry	profile,	3)	urinalysis,	4)	saline	429	
agglutination	test	(preferably	with	washing),	5)	Coombs’	test	or	flow	cytometric	analysis	if	the	saline	430	
agglutination	test	is	negative,	6)	coagulation	testing	for	thrombocytopenic	patients	and	patients	with	431	
clinical	signs	of	coagulopathy,	and	7)	tests	to	determine	if	any	underlying	disease	is	present	(e.g.,	drug	or	432	
toxin	exposure,	infection,	inflammation,	neoplasia,	other	autoimmune	diseases).	Our	survey	proved	that	433	
clinicians	choose	different	tests	to	diagnose	IMHA	and	that	laboratories	perform	tests	differently.	434	
Therefore,	it	is	recommended	that	veterinarians	contact	a	clinical	pathologist	or	technicians	or	435	
technologist	at	the	diagnostic	laboratory	they	use	to	obtain	details	about	the	reliability	of	specific	tests	436	
being	performed	to	diagnose	IMHA.	437	
	 	438	
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Table	1.	Clinical	pathology	findings	that	support	the	diagnosis	of	hemolytic	anemia.6	638	
CBC/Blood	smear	exam	 Serum	Biochemistry	 Urinalysis	
Increased	polychromasia	
Reticulocytosis	±	rubricytosis	±	Howell-Jolly	bodies	
Macrocytosis	&	anisocytosis	
Decreased	MCHC	e	or	increased	MCHC	i	
Spherocytes	e;	ghost	cells	I	–	immune-mediated	damage	or	other	
cause	
Heinz	bodies	e;	eccentrocytesI	–	oxidative	damage	
Hemoparasites	–	direct	physical	&/or	immune-mediated	damage	
Schistocytes	I;	acanthocytes	I;	keratocytes	I	–	direct	physical	
damage	
Hyperbilirubinemia	
Hemoglobinemia	i	
Decreased	haptoglobin	
concentration	i	
Decreased	hemopexin	
concentration	i	
Hyperbilirubinuria		
Hemoglobinuria	i	
Increased	urobilinogen	
e	=	specifically	associated	with	extravascular	hemolysis	639	
i	=	specifically	associated	with	intravascular	hemolysis	640	
MCHC	=	mean	cell	hemoglobin	concentration	641	
	 	642	
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Table	2.	Serum	biochemistry	results	associated	with	decreased	survival	in	IMHA	patients.	643	
Abnormality	 Species	 References	
Hyperbilirubinemia	 Dog	
Cat	
12–14,40	
37	
Hyperlactatemia	 Dog	 74	
Increased	alanine	aminotransferase	 Dog	 40	
Increased	aspartate	aminotransferase	 Dog	 40	
Increased	urea	nitrogen	 Dog	 40	
Increased	alkaline	phosphatase	 Dog	 12	
Hypoalbuminemia	(<	3.0	mg/dL)	 Dog	 13	
Hypophosphatemia	(<	3.5	mEq/L)	 Dog	 13	
Increased	creatine	kinase	(>	250	U/L)	 Dog	 13	
	 	644	
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Table	3.	Evidence	of	coagulation	abnormalities	in	dogs	with	IMHA.	645	
Abnormality	 Dogs	with	IMHA	affected	 References	
Increased	prothrombin	time	 10-28%	 14,15	
Increased	activated	partial	thromboplastic	time	 45-47%	 14,15	
Increased	fibrin	degradation	products	 57-60%	 14,15	
Increased	fibrinogen	 17/20	(85%)	 15	
Increased	D-dimers	 16/20	(80%)	 15	
Decreased	anti-thrombin	III	 10/20	(50%)	 15	
Increased	Russell	viper	venom	time	 7/20	(35%)	 15	
Increased	von	Willebrand	factor	associated	antigen	 9/20	(45%)	 15	
Increased	Kaolin	clotting	time	 3/20	(15%)	 15	
Increased	P-selectin*	 15/20	(75%)	 75	
Hypercoagulability	using	thromboelastography	 85-100%	 54–56	
Disseminated	intravascular	coagulation	 28-45%	 14,15	
Thromboemboli	found	at	necropsy	 20/25	(80%)	 14	
*	A	second	paper	saw	no	increase	in	P-selectin.13	 	646	
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Figure	Legends:	647	
Figure	1.	Proportions	(above	75%)	of	hematologic	parameters	reported	or	received	on	the	CBC	results	of	648	
patients	suspected	of	having	IMHA	by	survey	respondents	(n=94).	649	
	650	
Figure	2.	Microscopic	evidence	of	agglutination	in	a	wet-mount	saline	agglutination	test.	Peripheral	651	
blood	in	EDTA	(0.15%)	was	diluted	1:4	in	isotonic	saline	(0.9%	NaCl).	A	drop	of	the	mixture	was	placed	652	
on	a	glass	slide,	and	a	coverslip	was	placed	over	the	drop.	Grape-like	aggregates	of	erythrocytes	can	be	653	
observed	(unstained,	200×	magnification).	654	
	655	
Figure	3.	Survey	responses	indicating	the	post-transfusion	time-frame	in	days	(d)	during	which	656	
respondents	would	cautiously	interpret	hematologic	test	results	that	support	a	diagnosis	of	IMHA	657	
(n=94).	658	
Survey	of	Tests	Used	to	Diagnose	Immune	Mediated	Hemolytic	Anemia	(IMHA)	in	Veterinary	Medicine	
Designed	by	the	Diagnostic	Task	Force	of	the	Veterinary	and	Comparative	Clinical	Immunology	Society	
Data	from	this	survey	will	be	presented	at	the	ACVP/ASVCP	Meeting	in	November	2018.		Thank	you	for	
taking	the	time	to	answer	these	questions	about	the	diagnosis	of	IMHA.	
Question	Title	
1.	Which	parameters	do	you	report	or	receive	as	part	of	a	complete	blood	count	when	an	animal	is	
suspected	of	having	IMHA?		Please	check	all	that	apply.	
Packed	cell	volume	(PCV)	
Plasma	Total	Protein	(TP)	
Fibrinogen	using	heat	precipitation	
Fibrinogen	using	a	turbidimetric	assay	
Hemolysis	
Icterus	
Lipemia	
Red	blood	cell	(RBC)	count	
Hematocrit	
Hemoglobin	concentration	
Mean	corpuscular	volume	(MCV)	
Mean	corpuscular	hemoglobin	(MCH)	
Mean	corpuscular	hemoglobin	content	(MCHC)	
Red	cell	distribution	width	(RDW)	
Spherocytes	
Ghost	cells	
Acanthocytes	
Shistocytes	
Keratocytes	
Hemoparasites	
Relative	numbers	of	nucleated	RBCs	(nRBCs/100	WBCs)	
Absolute	nRBC	count	
Manual	reticulocyte	count	using	New	Methyene	Blue	
Manual	reticulocyte	count	using	Brilliant	Cresyl	Blue	
Automated	hematology	instrument	reticulocyte	count	
Average	mean	reticulocyte	volume	
Average	reticulocyte	hemoglobin	concentration	
Average	hemoglobin	content	of	reticulocytes	
White	blood	cell	count	
Automated	hematology	instrument	differential	count	
Manual	200-cell	differential	count	
Manual	100-cell	differential	count	
Blood	smear	review	by	a	board-certified	clinical	pathologist	
Saline	agglutination	test	at	a	1:1	dilution	
Saline	agglutination	test	at	a	1:4	dilution	
Saline	agglutination	test	without	extensive	washing	
Saline	agglutination	test	with	extensive	washing	
Saline	agglutination	test	by	macroscopic	evaluation	
Saline	agglutination	test	by	microscopic	evaluation		
Question	Title	
2.	If	not	already	included	in	the	CBC,	what	additional	testing	do	you	recommend	for	IMHA?		Please	
check	all	that	apply.	
Saline	agglutination	test	at	a	1:1	dilution	
Saline	agglutination	test	at	a	1:4	dilution	
Saline	agglutination	test	without	extensive	washing	
Saline	agglutination	test	with	extensive	washing	
Saline	agglutination	test	by	macroscopic	evaluation	
Saline	agglutination	test	by	microscopic	evaluation	
Direct	antigen	testing	using	Coombs'	test	only	if	there	is	no	auto-agglutination	
Direct	antigen	testing	using	Coombs'	test	with	or	without	auto-agglutination	
Direct	antigen	testing	using	Coombs'	test	at	37	degrees	C	
Direct	antigen	testing	using	Coombs'	test	at	4	degrees	C	
Direct	antigen	testing	using	a	Coombs'	test	microtiter	assay	
Direct	antigen	testing	using	a	Coombs'	test	gel	microcolumn	assay	
Direct	antigen	testing	using	a	Coombs'	test	immunochromatographic	strip	assay	
Direct	antigen	testing	using	a	Coombs'	test	capillary	assay	
Flow	cytometry	to	detect	anti-RBC	antibodies	
Biochemistry	panel	
Urinalysis	
Bone	marrow	aspiration	needle	biopsy	
Bone	marrow	core	biopsy	
Infectious	disease	screening	for	tick-borne	diseases	
Infectious	disease	screening	for	viral	diseases	
Infectious	disease	screening	for	a	large	panel	of	different	organisms	
Anti-nuclear	antigen	testing	
Osmotic	fragility	testing	
Diagnostic	imaging	
Question	Title	
3.	If	the	animal	was	transfused	recently,	do	you	interpret	test	results	more	cautiously?		Please	check	all	
that	apply.	
Yes,	if	the	transfusion	occurred	within	the	last	24	hours	
Yes,	if	the	transfusion	occurred	1-6	days	ago	
Yes,	if	the	transfusion	occurred	7-14	days	ago	
No	
Question	Title	
4.	Please	indicate	if	you	use	a	test	method	or	report	out	a	parameter	that	you	feel	supports	a	diagnosis	
of	IMHA,	but	was	not	listed	in	Question	1	or	Question	2.	
		
	
Appendix	B	
Saline	agglutination:	
The	following	is	a	very	basic	protocol	for	testing	for	agglutination.1		This	protocol	is	likely	to	give	some	
false	positive	results.2		Reagents	needed	include	isotonic	saline,	a	dropper,	a	clean	glass	microscope	
slide,	a	wooden	applicator	stick,	and	a	microscope.		Results	using	fresh	EDTA	blood	from	the	patient	
should	be	compared	to	fresh	EDTA	blood	from	a	normal	animal	of	the	same	species.	
● Place	one	drop	(50	µL)	of	saline	onto	a	glass	slide	
● Place	an	applicator	stick	in	a	tube	of	well-mixed	whole	blood	and	stir	
● Tap	the	blood-filled	applicator	stick	into	the	drop	of	saline	and	stir	
o This	should	produce	a	1:4	to	1:10	dilution	of	blood3	
o If	needed,	a	more	accurate	dilution	of	blood	can	be	tested	
▪ Add	5-10	µL	of	whole	blood	to	the	drop	of	saline	and	stir	
● Evaluate	the	slide	for	agglutination	macroscopically	and	microscopically	at	100×	magnification	
o Agglutination	appears	as	grape-like	clusters	of	RBCs	(Fig.	2)	and	must	be	distinguished	
from	rouleaux	where	erythrocytes	are	arranged	in	linear	stacks.	
o If	agglutination	is	present,	the	result	is	positive	and	supports	a	diagnosis	of	IMHA	
	
A	more	stringent	protocol	for	testing	for	agglutination	is	listed	below.1		This	protocol	can	give	some	false	
negative	results.		Reagents	needed	include	isotonic	saline,	a	clean	glass	microscope	slide,	micropipettes,	
a	centrifuge,	and	a	microscope.		Results	using	fresh	EDTA	blood	from	the	patient	should	be	compared	to	
fresh	EDTA	blood	from	a	normal	animal	of	the	same	species.	
● Wash	RBCs	
o Dilute	100	µL	of	whole	blood	in	900	µL	of	isotonic	saline	to	wash	the	RBCs	
o Centrifuge	the	sample	for	5	minutes	at	1500	×	g	to	pellet	the	RBCs	
o Remove	the	supernatant	
o Re-suspend	the	RBC	pellet	in	900	µL	of	isotonic	saline	
● Wash	the	sample	in	saline	(as	outlined	above)	at	least	2	additional	times	
● Place	50	µL	of	the	re-suspended	sample	onto	a	glass	slide	
● Evaluate	the	slide	for	agglutination	macroscopically	and	microscopically	at	100×	magnification	
o Agglutination	appears	as	grape-like	clusters	of	RBCs	(Fig.	2)	and	must	be	distinguished	
from	rouleaux	where	erythrocytes	are	arranged	in	linear	stacks.	
o If	agglutination	is	present,	the	result	is	positive	and	supports	a	diagnosis	of	IMHA	
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Appendix	C	
Coombs’	test:	
Test	kits	for	Coombs’	tests	are	available	for	dogs,	cats,	and	horses.1–3		Instructions	provided	in	the	kit	
should	be	followed.		Reagents	typically	include	rabbit	antiserum	that	has	been	adsorbed	with	normal	
species-specific	RBCs	so	that	the	reagents	are	unlikely	to	react	with	erythrocytes	from	healthy	animals.		
Blood	collected	in	EDTA,	ACD,	or	heparin	can	be	used.		Ideally,	results	using	fresh	whole	blood	from	the	
patient	should	be	compared	to	fresh	whole	blood	from	a	normal	animal	of	the	same	species.		However,	
samples	can	be	stored	at	4˚C	for	up	to	7	days	before	testing.4	
● Wash	RBCs	
o Centrifuge	blood	for	5	minutes	at	1500	×	g	
o Remove	100	µL	of	packed	RBCs	
o Add	4.9	mL	phosphate	buffered	saline	(PBS)	and	mix	
o Centrifuge	the	sample	for	5	minutes	at	1500	×	g	
o Remove	the	supernatant	
o Re-suspend	the	RBC	pellet	in	4.9	mL	PBS	
● Wash	the	sample	in	PBS	(as	outlined	above)	at	least	2	additional	times	
● Dilute	the	Coombs’	test	reagent	
o Label	2	sets	of	10	test	tubes:		1:2,	1:4,	1:8,	1:16,	1:32,	1:64,	1:128,	1:256,	auto,	neg	
▪ Note	that	the	use	of	microwell	titer	plates	in	place	of	test	tubes	can	dramatically	
reduce	the	amount	of	serum	needed.	
▪ Higher	dilutions	are	recommended	based	upon	the	findings	of	Piek	et	al..5	
o Add	100	µL	PBS	to	each	test	tube	
o Add	100	µL	species-specific	Coombs’	reagent	to	the	test	tube	labeled	1:2	
o Transfer	100	µL	solution	from	tube	1:2	to	tube	1:4	
o Transfer	100	µL	solution	from	tube	1:4	to	tube	1:8	
o Transfer	100	µL	solution	from	tube	1:8	to	tube	1:16	
o Transfer	100	µL	solution	from	tube	1:16	to	tube	1:32	
o Transfer	100	µL	solution	from	tube	1:32	to	tube	1:64	
o Transfer	100	µL	solution	from	tube	1:64	to	tube	1:128	
o Transfer	100	µL	solution	from	tube	1:128	to	tube	1:256	
● Perform	the	Coombs’	test	
o Add	100	µL	of	washed	RBCs	from	the	patient	to	test	tubes	1:2,	1:4,	1:8,	1:16,	1:32,	1:64,	
1:128,	1:256,	and	auto	
o Add	100	µL	of	washed	RBCs	from	the	normal	animal	to	test	tube	neg	
o Incubate	one	set	of	10	test	tubes	for	30	minutes	at	37˚C	
o Incubate	the	other	set	of	10	test	tubes	for	30	minutes	at	4˚C	
o Centrifuge	for	1	minute	at	1500	×	g	
o Hold	each	tube	up	to	the	light	at	a	45˚	angle	and	mix	by	tapping		
o If	RBCs	stay	in	a	pellet	or	break	off	in	clumps,	the	sample	is	positive	for	macro-
agglutination	
● Evaluate	the	slides	for	agglutination	macroscopically	and	microscopically	at	100×	magnification	
o Place	50	µL	each	sample	onto	glass	slides	
▪ Agglutination	appears	as	grape-like	clusters	of	RBCs	and	must	be	distinguished	
from	rouleaux	where	erythrocytes	are	arranged	in	linear	stacks	(Fig.	2).	
▪ If	agglutination	is	present,	the	result	is	positive	and	supports	a	diagnosis	of	
IMHA	
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